Suzhou Haowei Medical Technology Co., Ltd. specialized in the technological innovation with "Drug-Device Combination Products" technique as the core of vascular interventional embolization products to reflect the clinical unmet needs.
The founding team of the company is mainly from well-known biomedical and medical device companies at home and abroad. The main founders have more than 10 years of biomedical engineering experience, and have several decades of experience in the development and commercialization of Class III medical device products in the field of cardiovascular implantation and intervention.
Haowei Technology's core business is to continuously develop innovative vascular intervention products to meet the clinical needs of tumor chronic disease management, precision medical treatment driven by A1 and surgical robots, and "interventional non implantation".
The company's product treatment field involves systemic vascular interventional embolization therapy for malignant tumor intervention, benign myoma, nerve intervention, vascular malformations, and other systemic vascular interventional therapies.
